EUVIMEDEUVIMED entdecken
Open Access

KLC3 activates PI3K/AKT signaling and promotes ovarian cancer cell proliferation and migration through COL3A1

Jing Yang, Rongxia He, Xiaoling Zhang, Xing Wang, Min Liu, Xiaolong Liu, Yulan Li

Oncology Reports · 2025

DOI: 10.3892/or.2025.8900 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Oncology Reports, 2025. Verfasst von Jing Yang und 6 weiteren Autor:innen. Beteiligte Einrichtung: The First School of Clinical Medical, Lanzhou University, Lanzhou, Gansu 730000, P.R. China. Hauptthemen laut MEDLINE: Ovarian Neoplasms, Phosphatidylinositol 3-Kinases, Proto-Oncogene Proteins c-akt, Microtubule-Associated Proteins. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 41 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Ovarian NeoplasmsPhosphatidylinositol 3-KinasesProto-Oncogene Proteins c-aktMicrotubule-Associated ProteinsCollagen Type IIIHumansFemaleCell ProliferationCell MovementSignal TransductionAnimalsGene Expression Regulation, NeoplasticMiceCell Line, TumorEpithelial-Mesenchymal TransitionMiddle AgedXenograft Model Antitumor AssaysPrognosisKinesins

Stichwörter der Autor:innen

PI3K/AKT signaling pathwaycollagen type III α1kinesin light chain 3ovarian cancer

Substanzen

Phosphatidylinositol 3-KinasesProto-Oncogene Proteins c-aktMicrotubule-Associated ProteinsCOL3A1 protein, humanCollagen Type IIIKlc3 protein, mouseKinesins

Autor:innen und Institutionen

  • The First School of Clinical Medical, Lanzhou University, Lanzhou, Gansu 730000, P.R. China.
  • Department of Obstetrics, Lanzhou University Second Hospital, Lanzhou, Gansu 730000, P.R. China.
  • Department of Pathology, Gansu Provincial Hospital, Lanzhou, Gansu 730000, P.R. China.

Zitieren

APA

Yang, J., He, R., Zhang, X., Wang, X., Liu, M., Liu, X., & Li, Y. (2025). KLC3 activates PI3K/AKT signaling and promotes ovarian cancer cell proliferation and migration through COL3A1. Oncology Reports. https://doi.org/10.3892/or.2025.8900

Vancouver

Yang J, He R, Zhang X, Wang X, Liu M, Liu X, et al. KLC3 activates PI3K/AKT signaling and promotes ovarian cancer cell proliferation and migration through COL3A1. Oncology Reports. 2025. doi:10.3892/or.2025.8900

BibTeX
@article{Yang2025,
  author = {Yang, Jing and He, Rongxia and Zhang, Xiaoling and Wang, Xing and Liu, Min and Liu, Xiaolong and Li, Yulan},
  title = {KLC3 activates PI3K/AKT signaling and promotes ovarian cancer cell proliferation and migration through COL3A1},
  journal = {Oncology Reports},
  year = {2025},
  doi = {10.3892/or.2025.8900}
}
Kostenlos starten →